Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2007 | 1 |
2009 | 1 |
2016 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
Nature. 2016 Oct 27;538(7626):477-482. doi: 10.1038/nature19830. Epub 2016 Oct 19.
Nature. 2016.
PMID: 27760111
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor.
Szlavik Z, Csekei M, Paczal A, Szabo ZB, Sipos S, Radics G, Proszenyak A, Balint B, Murray J, Davidson J, Chen I, Dokurno P, Surgenor AE, Daniels ZM, Hubbard RE, Le Toumelin-Braizat G, Claperon A, Lysiak-Auvity G, Girard AM, Bruno A, Chanrion M, Colland F, Maragno AL, Demarles D, Geneste O, Kotschy A.
Szlavik Z, et al. Among authors: proszenyak a.
J Med Chem. 2020 Nov 25;63(22):13762-13795. doi: 10.1021/acs.jmedchem.0c01234. Epub 2020 Nov 4.
J Med Chem. 2020.
PMID: 33146521
Item in Clipboard
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its Analogues.
Sipos S, Bálint B, Szabó ZB, Ondi L, Csékei M, Szlávik Z, Proszenyák Á, Murray JB, Davidson J, Chen I, Dokurno P, Surgenor AE, Pedder C, Hubbard RE, Maragno AL, Chanrion M, Colland F, Geneste O, Kotschy A.
Sipos S, et al. Among authors: proszenyak a.
ACS Omega. 2021 Aug 18;6(34):22073-22102. doi: 10.1021/acsomega.1c02595. eCollection 2021 Aug 31.
ACS Omega. 2021.
PMID: 34497901
Free PMC article.
Item in Clipboard
Screening of agelasine D and analogs for inhibitory activity against pathogenic protozoa; identification of hits for visceral leishmaniasis and Chagas disease.
Vik A, Proszenyák A, Vermeersch M, Cos P, Maes L, Gundersen LL.
Vik A, et al. Among authors: proszenyak a.
Molecules. 2009 Jan 8;14(1):279-88. doi: 10.3390/molecules14010279.
Molecules. 2009.
PMID: 19136916
Free PMC article.
Item in Clipboard
Oxamides as novel NR2B selective NMDA receptor antagonists.
Barta-Szalai G, Borza I, Bozó E, Kiss C, Agai B, Proszenyák A, Keseru GM, Gere A, Kolok S, Galgóczy K, Horváth C, Farkas S, Domány G.
Barta-Szalai G, et al. Among authors: proszenyak a.
Bioorg Med Chem Lett. 2004 Aug 2;14(15):3953-6. doi: 10.1016/j.bmcl.2004.05.053.
Bioorg Med Chem Lett. 2004.
PMID: 15225705
Item in Clipboard
Synthesis, antimicrobial and antineoplastic activities for agelasine and agelasimine analogs with a beta-cyclocitral derived substituent.
Proszenyák A, Charnock C, Hedner E, Larsson R, Bohlin L, Gundersen LL.
Proszenyák A, et al.
Arch Pharm (Weinheim). 2007 Dec;340(12):625-34. doi: 10.1002/ardp.200700137.
Arch Pharm (Weinheim). 2007.
PMID: 17994607
Item in Clipboard
Cite
Cite